![](https://cdn-api.swapcard.com/public/images/42c6ffac02a4437aad82ffbc33b14609.png)
![](https://img.swapcard.com/?u=https%3A%2F%2Fcdn-api.swapcard.com%2Fpublic%2Fimages%2F60012bc7c3b744c6bc01cd1f9b2a4d74.png&q=0.8&m=fit&w=400&h=200)
Negev Capital
Reception Partner
Information
Negev Capital is a psychedelic medical intervention investment fund with assets of USD$30+ million. The Company invests in drug discovery, with a focus on preclinical and/or Phase 1 stages of development. They aim to support those early-stage companies in need of capital that promote the thoughtful, responsible, medical use of psychedelic medication for psychiatric disorders, and who have excellent management and science teams, and solid IP.